(Q34661925)

3 August 2017

title

Kinetics of l-5-hydroxytryptophan in healthy subjects (English)

1 reference

3 August 2017

H. G. Westenberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6187038

24 August 2023

T. W. Gerritsen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6187038

24 August 2023

B. A. Meijer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6187038

24 August 2023

H. M. van Praag

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6187038

24 August 2023

language of work or name

English

0 references

publication date

1 December 1982

1 reference

full work available at URL

3 August 2017

https://api.elsevier.com/content/article/PII:0165178182900749?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

https://api.elsevier.com/content/article/PII:0165178182900749?httpAccept=text/plain

24 August 2023

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

24 August 2023

1 reference

3 August 2017

volume

7

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

373-385

1 reference

5-Hydroxytryptophan: A method for monitoring human plasma content during clinical administration

3 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Penicillamine kinetics in normal subjects.

24 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Clinical pharmacokinetics of levodopa in parkinson's disease

24 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine--studies in patients with peptic ulcer disease

24 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam

24 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Influence of route of administration on physiological availability of levodopa in dogs

24 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements

24 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Potentiation of the central actions of 5-hydroxytryptophan in rabbits by DL-alpha-hydrazino-alpha-methyldopa.

24 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Effect of 5-hydroxytryptophan (5-HTP) on growth hormone and ACTH release in man

24 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

The determination of 5-hydroxytryptophan and its metabolites in plasma following administration to man

24 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Effect of 5-Hydroxytryptophan (5-HTP) on Plasma Prolactin Levels in Man

24 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

The serum level approach to individualization of drug dosage

24 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Pharmacokinetics of carbamazepine in normal man

24 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

The Effects of Aromatic Amino Acid Decarboxylase Inhibitors on Plasma Concentrations of 5-Hydroxytryptophan in Man

24 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Pharmacokinetics of Intravenously Administered L-5-Hydroxytryptophan in Man

24 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Bioavailability and Related Pharmacokinetics in Man of Orally Administered L-5-Hydroxytryptophan in Steady State

24 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Influence of food on the absorption of phenytoin in man

24 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Pharmacokinetics and bioavailability of cimetidine in humans.

24 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Inhibition of DOPA decarboxylase by the hydrazino analog of alpha-methylDOPA

24 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

L-3,4-dihydroxyphenylalanine metabolism by the gut in vitro

24 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Influence of route of administration on drug availability

24 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Mechanism of intestinal absorption and brain uptake of L-5-hydroxytryptophan in rats, as compared to those of L-3,4-dihydroxyphenylalanine

24 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Whole-body autoradiographic studies on the distribution of 14C-labeled D- and L-5-hydroxytryptophan, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid in rats

24 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

l-5-Hydroxytryptophan in depression: the first substitution therapy in psychiatry? The treatment of 99 out-patients with 'therapy-resistant' depressions.

24 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Management of depression with serotonin precursors

24 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Long-Term Therapy of Myoclonus and Other Neurologic Disorders with L-5-Hydroxytryptophan and Carbidopa

24 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

Behavioral Changes of Chronic Schizophrenic Patients Given L-5-Hydroxytryptophan

24 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90074-9

24 August 2023

Identifiers

1 reference

3 August 2017

1 reference